IT IS A CENTURY-old way of treating viral diseases. In Covid-19, though, the use of antibody-rich convalescent plasma (CP), has been controversial given the lack of strong evidence.
“Ours is the world’s largest trial [of its kind] on plasma therapy,” Dr Balram Bhargava, director-general, Indian Council of Medical Research (ICMR), said in response to THE WEEK’s query on the plasma therapy (PLACID) trial. “The trial has been conducted on 464 patients, where 235 patients with moderate Covid-19 disease were given plasma, the rest were given best standard care. This was done in 39 hospitals across India, and we looked at whether it led to severe disease or death over 28 days.” The results of the open label, randomised controlled trial (RCT) published as a pre-print (peer-review pending) suggest that there was no difference in 28-day mortality or progression to severe disease among those studied.
“The study also indicates that the key point here is the high titre [levels] of neutralising antibodies for it to work, if at all,” said professor Sunit K. Singh, head, molecular biology, Banaras Hindu University. “Besides, we have to be sure that the donor does not have any viral RNA in their blood.”
ãã®èšäºã¯ THE WEEK ã® September 20, 2020 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã8,500 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã ?  ãµã€ã³ã€ã³
ãã®èšäºã¯ THE WEEK ã® September 20, 2020 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã8,500 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã? ãµã€ã³ã€ã³
There Is A Wind Blowing Against The BJP, And It Will Only Pick Up Speed
Interview - Akhilesh Yadav, Former Chief Minister, Uttar Pradesh
Between hospital and home
Transitional care centres can add a lot to India's health care system
EFFORT VS EFFECT
The government's attempts to ensure quality drugs is evident, but how well new policies can be monitored on the ground remains to be seen
A way to let go of fear
Accepting the use of adult diapers is a journey with various stages-denial, concealment, rejection and reluctance
Mandeeps & a miracle
Two strangers, one deadly disease and an act of kindness. How Mandeep Mann saved Mandeep Singh, an acute leukaemia patient, by donating his stem cells
The A, B, C of cosmetic surgery
Between eight to 10 lakh cosmetic surgeries happen in India every year. Who is an ideal candidate, and what are the risks and results you can expect?
Vaccines and meningitis
In sub-Saharan Africa, from Senegal in the west to Ethiopia in the east, and encompassing the northern part of Nigeria, there exists a region known as the African Meningitis Belt (AMB).
Celebrating diversity and inclusivity
As Indians battle it out in our nation's 18th general election, it is again time for voters to reflect on the \"Idea of India\"-or rather, on two duelling ideas of India that are now before us and between which the nation must choose at the ballot box.
Defendant: an HermÚs handbag
When HermÚs was hit with a class-action lawsuit last month for \"antitrust\" activities, it didn't see it coming. Most of the luxury world has all eyes on this suit, filed by two interested consumers who claim they were denied a purchase, and whether it would go to trial.
A legacy, bound
Amal Allana's biography of her father, Ebrahim Alkazi, is as much personal as it is historical